This website uses cookies to ensure you get the best experience on our website.
Accept Cookies
Learn More
Green Journals
Home
Hijacked
Contact Us
More
Simulation
Green Recruitments
About Us
Blog
Login
Register
English
English
Français
العربية
Journal Report
ONCOLOGIST
Download PDF
Print
Journal Information
Journal Title
ONCOLOGIST
Publisher
OXFORD UNIV PRESS
ISSN
1083-7159
E-ISSN
1549-490X
Database
Clarivate
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year
A+
A
B
C
2026
✓
✓
2025
✓
✓
2024
✓
✓
2023
✓
✓
2021/2022
✓
✓
2020
✓
✓
2019
✓
✓
2018
✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Sex Differences in Liver Metastases at Diagnosis Across Early- and Average-Onset Gastrointestinal Adenocarcinomas
Nadia Kirmani, Rania Abdusamad, Rishi V Parikh et al.
2026-11-13
DOI:
10.1093/oncolo/oyag437
RWE: what is its regulatory fate?
Francesco Perrone
2026-11-12
DOI:
10.1093/oncolo/oyag297
A prospective trial of a personalized exercise program in patients with advanced prostate cancer
Benjamin L Maughan, Georges Gebrael, Neeraj Agarwal et al.
2026-11-12
DOI:
10.1093/oncolo/oyag452
Real-World LAG3 Expression as A Biomarker in Advanced Melanoma: Implications for Treatment Selection
Inderjit Mehmi, Jonathan E Cohen, Kathryn Bollin et al.
2026-11-12
DOI:
10.1093/oncolo/oyag441
Patient-reported outcomes from ASCENT-03: sacituzumab govitecan vs chemotherapy in advanced triple-negative breast cancer
Kevin Punie, Sara M Tolaney, Sara A Hurvitz et al.
2026-11-12
DOI:
10.1093/oncolo/oyag448
Treatment Hotspots and Controversies in Papillary Thyroid Microcarcinoma
Lixia Yu, Fan Liu, Fei Wang et al.
2026-11-10
DOI:
10.1093/oncolo/oyag216
Cholesterol transporters and immune-metabolic features in patients with metastatic renal cell carcinoma receiving immunotherapy combinations
Giulia Claire Giudice, Hassan Mohammed Abushukair, Giulia Mazzaschi et al.
2026-11-6
DOI:
10.1093/oncolo/oyag430
TAVO412, an Anti-EGFR, cMET and VEGF Trispecific Antibody: Initial Results from a Phase I Dose Escalation Study in Patients with Advanced Solid Tumors
Chao Han, Hong Xie, Yanjiao Yu et al.
2026-11-6
DOI:
10.1093/oncolo/oyag444
National Gaps in Appendiceal Cancer Care and Implementation of a Regional Virtual Multidisciplinary Care Conference
Harveen Kaur, Jenna Nimer, Emily Fenton et al.
2026-11-6
DOI:
10.1093/oncolo/oyag439
Tumor Longevity: a time-dependent biomarker of immune checkpoint inhibitor responsiveness across head and neck, lung, renal and urothelial cancers
Rebecca Romanò, Chiara Airoldi, Salvatore Alfieri et al.
2026-11-6
DOI:
10.1093/oncolo/oyag445
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 13, 2026 13:27